Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 3683

FDA approves Liquidia's inhaled hypertension drug in two settings

$
0
0
The FDA approved Liquidia’s treprostinil program for two related kinds of high blood pressure, turning up the heat on rival United Therapeutics and its Tyvaso franchise. Treprostinil, now branded as Yutrepia, is indicated for patients ...

Viewing all articles
Browse latest Browse all 3683

Trending Articles